A Partner Who Thinks in Multiples, Not Just Licenses
For investors and family offices evaluating, structuring, or growing healthcare assets across the UAE and GCC.
Healthcare looks like an attractive asset class from the outside — recurring revenue, demographic tailwinds, insurer-backed billing — and looks considerably more complicated once diligence starts. Regulatory fragmentation across DHA, DOH, MOHAP, and free zones complicates underwriting. Valuation benchmarks for UAE healthcare assets are thin and inconsistently reported. Most advisors available in this market can confirm an asset is compliant but can't speak to what drives its valuation.
How MedGrowth Is Built for This
We sit inside the entire lifecycle, not just the transaction at the end — which means we can evaluate a target's regulatory standing, operational performance, and growth trajectory in the same engagement, rather than requiring three separate advisors to stitch that picture together. For greenfield investment, the same feasibility and financial modeling used in Business Setup & Launch applies directly to underwriting a new facility. For acquisitions, Transactions & M&A Advisory brings healthcare-specific due diligence that a generalist advisor typically misses. For portfolio growth, Growth Advisory and Operational Excellence apply standardized playbooks across multiple assets.
What That Looks Like
A feasibility study and financial model before capital commitment.
Healthcare-specific due diligence on an acquisition target.
A growth plan for a portfolio asset, benchmarked against comparable facilities.
Valuation support when an exit is the right next move.
Let's talk about where you are
Book a consultation and we'll map the right next step for your stage.
